EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Selective in vitro Synergistic Evaluation of Probiotic Tolerant morpholinyl- and 4-ethylpiperazinyl-Imidazole-chalcone Derivatives on Gastrointestinal System Pathogens

Tuncay Söylemez, Zafer Asım Kaplancıklı, Derya Osmaniye, Yusuf Özkay, Fatih Demirci

Current Microbiology · 2024

DOI: 10.1007/s00284-024-03788-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Microbiology, 2024. Verfasst von Tuncay Söylemez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institut Für Lebensmittelchemie, Gottfried Wilhelm Leibniz Universität Hannover, Callinstraße 5, 30167, Hannover, Germany. tuncay.soylemez@lci.uni-ha…. Hauptthemen laut MEDLINE: Probiotics, Imidazoles, Microbial Sensitivity Tests, Drug Synergism. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gottfried Wilhelm Leibniz Universität Hannover.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Imidazole-chalcone compounds are recognised for their broad-spectrum antimicrobial properties. Probiotic-friendly, selective new-generation antimicrobials prove to be more efficient in combating gastrointestinal system pathogens. The aim of this study is to identify imidazole-chalcone derivatives that probiotics tolerate and evaluate their in vitro synergistic antimicrobial effects on pathogens. In this study, fifteen previously identified imidazole-chalcone derivatives were analyzed for their in vitro antimicrobial properties against gastrointestinal microorganisms. Initially, the antimicrobial activity of pathogens was measured using the agar well diffusion method, while the susceptibility of probiotics was determined by microdilution. The chosen imidazole-chalcone derivatives were assessed for synergistic effects using the checkerboard method. Four imidazole-chalcone derivatives to which probiotic bacteria were tolerant exhibited antibacterial and antifungal activity against the human pathogens tested. To our knowledge, this study is the first to reveal the fractional inhibitory concentration (FIC) of combinations of imidazole-chalcone derivatives. Indeed, the minimum inhibitory concentrations (MIC) for morpholinyl- (ZDO-3f) and 4-ethylpiperazinyl- (ZDO-3 m) imidazole-chalcones were notably low when tested against E. coli and B. subtilis , with values of 31.25 μg/mL and 125 μg/mL, respectively. The combination of morpholinyl- and 4-ethylpiperazinyl derivatives demonstrated an indifferent effect against E. coli , but an additive effect was observed for B. subtilis . Additionally, it was observed that imidazole-chalcone derivatives did not exhibit any inhibitory effects on probiotic organisms like Lactobacillus fermentum (CECT-5716), Lactobacillus rhamnosus (GG), and Lactobacillus casei (RSSK-591). This study demonstrates that imidazole-chalcone derivatives that are well tolerated by probiotics can potentially exert a synergistic effect against gastrointestinal system pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsImidazolesMicrobial Sensitivity TestsDrug SynergismChalconeAnti-Bacterial AgentsChalconesGastrointestinal TractHumansBacteriaAntifungal Agents

Substanzen

ImidazolesChalconeAnti-Bacterial AgentsChalconesAntifungal Agentsimidazole

Autor:innen und Institutionen

  • Institut Für Lebensmittelchemie, Gottfried Wilhelm Leibniz Universität Hannover, Callinstraße 5, 30167, Hannover, Germany. tuncay.soylemez@lci.uni-hannover.de.
  • Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, Eskişehir, Türkiye.
  • Faculty of Pharmacy, Pharmacognosy Department, Anadolu University, Eskişehir, Türkiye.
  • Faculty of Pharmacy, Eastern Mediterranean University, Famagusta, N. Cyprus, Cyprus.

Förderung

  • Gottfried Wilhelm Leibniz Universität Hannover

Zitieren

APA

Söylemez, T., Kaplancıklı, Z. A., Osmaniye, D., Özkay, Y., & Demirci, F. (2024). Selective in vitro Synergistic Evaluation of Probiotic Tolerant morpholinyl- and 4-ethylpiperazinyl-Imidazole-chalcone Derivatives on Gastrointestinal System Pathogens. Current Microbiology. https://doi.org/10.1007/s00284-024-03788-5

Vancouver

Söylemez T, Kaplancıklı ZA, Osmaniye D, Özkay Y, Demirci F. Selective in vitro Synergistic Evaluation of Probiotic Tolerant morpholinyl- and 4-ethylpiperazinyl-Imidazole-chalcone Derivatives on Gastrointestinal System Pathogens. Current Microbiology. 2024. doi:10.1007/s00284-024-03788-5

BibTeX
@article{Sylemez2024,
  author = {Söylemez, Tuncay and Kaplancıklı, Zafer Asım and Osmaniye, Derya and Özkay, Yusuf and Demirci, Fatih},
  title = {Selective in vitro Synergistic Evaluation of Probiotic Tolerant morpholinyl- and 4-ethylpiperazinyl-Imidazole-chalcone Derivatives on Gastrointestinal System Pathogens},
  journal = {Current Microbiology},
  year = {2024},
  doi = {10.1007/s00284-024-03788-5}
}
Kostenlos starten →